Continuous glucose monitors (CGMs) are monitoring devices people with diabetes use. They apply them directly to the skin and ...

DexCom develops continuous glucose monitoring (CGM) systems to help people with diabetes track their blood glucose levels.

The global continuous glucose monitoring (CGM) systems industry is poised for remarkable growth, surging from USD 11.1 ...

Over-the-counter continuous glucose monitors empower consumers with valuable health insights without the need for a doctor’s ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

The CGM sensor, which is being developed by Abbott to work exclusively with Medtronic devices, will be sold by the latter.

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

Ultrahuman, best known for its smart rings, has launched its continuous glucose monitor in the US. The device was first released in the UK in June 2021. The Ultrahuman M1 CGM can be purchased with ...

Argentina’s diabetes devices market experiences robust advancement, bolstered by youth-specific solutions, smart sensors, and ...

The American Diabetes Association (ADA)’s Standards of Care — 2025 offer new guidance on broader use of continuous glucose monitoring (CGM), use of glucagon-like peptide 1 receptor agonists ...